The Carter review: how are hospitals measuring up?

January 25, 2019

Two years on from Lord Carter’s 2016 review of hospital efficiency, The Pharmaceutical Journal looks at the progress pharmacy departments in England are making towards meeting his challenging targets.

Spotlight

Lusochimica S.p.A.

Lusochimica S.p.A. is an Italian manufacturer of bulk active ingredients for pharmaceuticals (API), having sales offices in Milan and two production plants in Lomagna and Pisa, whose production processes strictly comply with international cGMP standards. Founded in 1964 and belonging to Menarini Group since 1984, Lusochimica S.p.A. incorporated former Laboratori Guidotti Fine Chemicals division starting January 2009, as a result of restructuring of Fine Chemicals operations within Menarini Group.

Other Infographics
news image

What Does The Pharma IndustryWant From CROs?

Infographic | June 16, 2022

Use Informa Pharma Intelligence’s marketing and pharma expertise to conduct industry research, produce engaging thought leadership content,

Read More
news image

Do patients actually watch all those pharma TV ads?

Infographic | January 13, 2020

Fewer than one in eight chronic-disease sufferers say they watch when a drug commercial comes on TV, according to one recent study of community users. And for the millennials among them, the percentage is even less so. That’s despite the $5.1 billion spent by biopharma on the medium in 2018. We take a look at these data points and many others from two recent studies on the media habits of patients and doctors.

Read More
news image

COVID-19 Summary as of March 13, 2020

Infographic | April 6, 2020

Biomedtracker and Trialtrove have a total of 307 clinical trials for the treatment of COVID-19. 152 initiated trials for the treatment of COVID-19. 155 Trials have been announced but have not yet begun recruitment.

Read More
news image

2021 global life sciences outlook

Infographic | August 24, 2021

The life sciences sector has played a pivotal role amid the COVID-19 pandemic. To cope with the global crisis, traditional competitors partnered to accelerate research and develop the fastest novel vaccine in the history. Governments, health systems, payers, retail pharmacies, and nonprofits are now working collaboratively with the sector to provide widespread distribution and administration.

Read More
news image

Taking Pharmacy Benefits on a New Ride

Infographic | December 1, 2019

Rideshare companies like Uber and Lyft challenged the old way of doing things with a new approach. It’s not just about getting from point A to point B anymore, it’s about the experience, convenience and added value. The same applies to pass-through PBMs (pharmacy benefit managers) that are challenging the status quo to make prescriptions more affordable..

Read More
news image

Cancer Drugs Bring in Most Pharma Revenue

Infographic | February 25, 2020

Worldwide cancer drug sales are already way ahead of those of other drugs and the revenue generated by them is expected to grow even larger by 2024. This is according to a report recently released by consultancy Evaluate, which analyses trends in the pharmaceutical sector. According to Evaluate's calculations, oncology drugs reached US$123.8 billion in sales in 2018, more than double that of the next item on the list, drugs treating diabetes with US$48.5 billion dollars in sales. By 2024, cancer drug sales are expected to almost double to US$236.6 billion dollars.

Read More

Spotlight

Lusochimica S.p.A.

Lusochimica S.p.A. is an Italian manufacturer of bulk active ingredients for pharmaceuticals (API), having sales offices in Milan and two production plants in Lomagna and Pisa, whose production processes strictly comply with international cGMP standards. Founded in 1964 and belonging to Menarini Group since 1984, Lusochimica S.p.A. incorporated former Laboratori Guidotti Fine Chemicals division starting January 2009, as a result of restructuring of Fine Chemicals operations within Menarini Group.

Events